Valneva Se ADR (VALN) Stock Price, Quote & News

Company Profile

Valneva SE, a specialty vaccine company, develops, manufactures, and commercializes prophylactic vaccines for infectious diseases with unmet needs. It offers IXIARO, an inactivated Vero cell culture-derived Japanese encephalitis vaccine indicated for active immunization against Japanese encephalitis; DUKORAL, an oral vaccine for the prevention of diarrhea caused by Vibrio cholera or heat-labile toxin producing enterotoxigenic Escherichia coli bacterium; and IXCHIQ/ VLA1553, a single-dose, live-a...

Industry: Biotechnology

Sector: Healthcare

Phone: 33 2 28 07 37 10

Fax: 33 2 28 07 37 11

Website: valneva.com

Address:

6 rue Alain Bombard, Saint-Herblain, France

alexpitti Jul. 17 at 8:50 PM

$VALN I meeting with management next week. any questions

1 · Reply

ted_the_trader Jul. 17 at 9:42 AM

$VALN

0 · Reply

Filosofem Jul. 14 at 2:50 PM

$VALN https://valneva.com/press-release/valneva-announces-lifting-of-european-medicines-agencys-temporary-restriction-on-use-of-chikungunya-vaccine-ixchiq-in-elderly/?lang=de

0 · Reply

Thestocktraderhubzee Jul. 14 at 10:11 AM

WATCHLIST JUL 14 2025. $VALN Valneva's Chikungunya Vaccine IXCHIQ Cleared By European Medicines Agency For Use In Seniors After Safety Committee Review $SOFI TD Cowen Initiates Coverage On SoFi Technologies with Hold Rating, Announces Price Target of $21 $DTCK Davis Commodities Intends To Evaluate Establishment Of Strategic Reserve In Solana, As Part Of Digital Innovation And Treasury Diversification Roadmap $FBK Keefe, Bruyette & Woods Upgrades FB Financial to Outperform, Raises Price Target to $58 $MAG MAG Silver shares are trading higher after the company announced it will be acquired by Pan American Silver Corp for $2.1 billion.

0 · Reply

baerenmarkt Jul. 14 at 8:36 AM

$VALN Send it.

0 · Reply

Fib7867 Jul. 6 at 4:59 PM

#myVALNanalysis $VALN

0 · Reply

Boonkers Jun. 30 at 4:36 AM

$VALN

0 · Reply

Siuolman58 Jun. 27 at 1:12 PM

Ticks spread to new regions across America, bringing dangerous diseases and need for vigilance $VALN https://www.foxnews.com/travel/ticks-spread-regions-across-america-bringing-dangerous-diseases-need-vigilance

1 · Reply

PenkeTrading Jun. 26 at 5:45 AM

I found you an Oversold RSI (Relative Strength Index) on the daily chart of Valneva SE ADR. Is that bullish or bearish? $VALN #RsiOversold #NASDAQ

0 · Reply

Siuolman58 Jun. 17 at 7:48 PM

$VALN Just waiting for the Lyme Vaccine!!! Big Winner!

0 · Reply

Valneva Announces Lifting of European Medicines Agency's Temporary Restriction on Use of Chikungunya Vaccine IXCHIQ® in Elderly

Jul 11, 2025, 8:18 AM EDT - 6 days ago

Europe lifts restriction on Valneva's chikungunya vaccine for elderly adults

Jun 26, 2025, 1:00 AM EDT - 22 days ago

Valneva Announces Exclusive Vaccine Marketing and Distribution Agreement for Germany with CSL Seqirus

Jun 25, 2025, 11:45 AM EDT - 22 days ago

Valneva Announces Successful Outcome of its Annual General Meeting, Confirms FY 2025 guidance

Jun 9, 2025, 10:29 AM EDT - 5 weeks ago

UK's MHRA suspends Valneva's chikungunya vaccine for elderly

Jun 5, 2025, 11:45 AM EDT - 6 weeks ago

Valneva Reports Positive Six-Month Antibody Persistence and Safety Phase 2 Results in Children for its Single-Shot Chikungunya Vaccine IXCHIQ®

Jun 4, 2025, 1:00 AM EDT - 6 weeks ago

Valneva Announces Availability of Documentation for its Combined Shareholder Meeting and Provides Corporate Update

May 26, 2025, 11:30 AM EDT - 7 weeks ago

Valneva to Participate at U.S. and European Investor Conferences in June

May 12, 2025, 1:00 AM EDT - 2 months ago

Valneva Provides Update on Recommended Use of IXCHIQ® by Elderly Individuals in the United States

May 9, 2025, 9:47 AM EDT - 2 months ago

Valneva SE (VALN) Q1 2025 Earnings Call Transcript

May 8, 2025, 12:30 AM EDT - 2 months ago

Valneva SE: Still Undervalued Travel Vaccine Bet With Robust 2025 Guidance

May 7, 2025, 11:45 AM EDT - 2 months ago

Valneva Provides Update Following European Medicines Agency Announcement on Use of IXCHIQ® in Elderly

May 7, 2025, 8:40 AM EDT - 2 months ago

Europe reviews Valneva's chikungunya vaccine after reports of serious side-effects in older people

May 7, 2025, 1:00 AM EDT - 2 months ago

Valneva Reports First Quarter 2025 Financial Results and Provides Corporate Updates

Apr 26, 2025, 1:10 PM EDT - 2 months ago

Valneva Provides Update on Recommendation for Use of Its Chikungunya Vaccine by French Authorities

Apr 18, 2025, 4:00 AM EDT - 3 months ago

Valneva Provides Update on ACIP Recommendation for its Chikungunya Vaccine IXCHIQ® Among U.S. Travelers

Apr 16, 2025, 11:45 AM EDT - 3 months ago

Valneva to Participate in Multiple Events at the 25th World Vaccine Congress, including a Presentation on its Chikungunya Vaccine IXCHIQ®

Apr 14, 2025, 2:28 PM EDT - 3 months ago

Brazil Approves Valneva's Mosquito-Borne Chikungunya Vaccine

Apr 14, 2025, 11:45 AM EDT - 3 months ago

Valneva Receives First Marketing Authorization for IXCHIQ® in a Chikungunya Endemic Country

Apr 9, 2025, 1:00 AM EDT - 3 months ago

Valneva and LimmaTech Announce First Vaccination in Phase 2 Infant Study of Tetravalent Shigella Vaccine Candidate S4V2

Apr 7, 2025, 9:33 AM EDT - 3 months ago

VALN Investors Have Opportunity to Join Valneva SE Fraud Investigation with the Schall Law Firm

Apr 3, 2025, 11:45 AM EDT - 3 months ago

Valneva SE Shareholding Declaration - March 2025

Apr 1, 2025, 11:45 AM EDT - 3 months ago

Valneva's Chikungunya Vaccine IXCHIQ® Now Authorized in EU for Adolescents Aged 12 and Above

Mar 31, 2025, 1:00 AM EDT - 3 months ago

Valneva Submits Adolescent Label Extension Application for its Chikungunya Vaccine, IXCHIQ®, to UK MHRA

Mar 26, 2025, 1:00 PM EDT - 4 months ago

Valneva Renews its Sales Agreement in connection with its Existing At-the-Market (ATM) Program

Mar 25, 2025, 2:00 AM EDT - 4 months ago

Valneva Announces Filing of 2024 Universal Registration Document and US Form 20-F

Mar 24, 2025, 2:00 AM EDT - 4 months ago

Valneva Responds to French Government's Call for Vaccine Supply of IXCHIQ® against Chikungunya Outbreak in La Réunion

Mar 20, 2025, 8:00 PM EDT - 4 months ago

Valneva SE (VALN) Q4 2024 Earnings Call Transcript

Mar 20, 2025, 10:00 AM EDT - 4 months ago

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Valneva SE (VALN) and Encourages Stockholders to Learn More About the Investigation

Mar 20, 2025, 2:00 AM EDT - 4 months ago

Valneva Reports Full Year 2024 Results and Provides Business Updates and Outlook

Mar 19, 2025, 10:00 AM EDT - 4 months ago

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Valneva SE (VALN) And Encourages Shareholders to Reach Out

Mar 18, 2025, 10:00 AM EDT - 4 months ago

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Valneva SE (VALN) and Encourages Shareholders to Learn More About the Investigation

Mar 17, 2025, 10:00 AM EDT - 4 months ago

Valneva SE (VALN) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation

Mar 16, 2025, 10:00 AM EDT - 4 months ago

Bronstein, Gewirtz & Grossman, LLC Encourages Valneva SE (VALN) Shareholders to Inquire about Securities Investigation

Mar 14, 2025, 10:00 AM EDT - 4 months ago

Bronstein, Gewirtz & Grossman, LLC Is Investigating Valneva SE (VALN) And Encourages Investors to Connect

Mar 13, 2025, 10:00 AM EDT - 4 months ago

Bronstein, Gewirtz & Grossman, LLC Encourages Valneva SE (VALN) Stockholders to Inquire about Securities Investigation

Mar 12, 2025, 10:00 AM EDT - 4 months ago

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Valneva SE (VALN) and Encourages Investors to Learn More About the Investigation

Mar 11, 2025, 10:00 AM EDT - 4 months ago

Valneva SE (VALN) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation

Mar 9, 2025, 10:00 AM EDT - 4 months ago

Bronstein, Gewirtz & Grossman, LLC Is Investigating Valneva SE (VALN) And Encourages Stockholders to Connect

Mar 7, 2025, 10:00 AM EST - 4 months ago

Valneva SE (VALN) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation

Mar 6, 2025, 10:00 AM EST - 4 months ago

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Valneva SE (VALN) and Encourages Stockholders to Learn More About the Investigation.

Mar 5, 2025, 10:00 AM EST - 4 months ago

Bronstein, Gewirtz & Grossman, LLC Encourages Valneva SE (VALN) Investors to Inquire about Securities Investigation

Mar 4, 2025, 1:45 PM EST - 4 months ago

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Valneva SE (VALN) And Encourages Investors to Reach Out

Mar 3, 2025, 1:00 AM EST - 4 months ago

Valneva to Present at Upcoming TD Cowen and Van Lanschot Kempen Healthcare Investor Conferences

Feb 28, 2025, 11:45 AM EST - 4 months ago

Valneva Receives EMA's Positive CHMP Opinion for Adolescent Label Extension for Chikungunya Vaccine IXCHIQ®

alexpitti Jul. 17 at 8:50 PM

$VALN I meeting with management next week. any questions

1 · Reply

ted_the_trader Jul. 17 at 9:42 AM

$VALN

0 · Reply

Filosofem Jul. 14 at 2:50 PM

$VALN https://valneva.com/press-release/valneva-announces-lifting-of-european-medicines-agencys-temporary-restriction-on-use-of-chikungunya-vaccine-ixchiq-in-elderly/?lang=de

0 · Reply

Thestocktraderhubzee Jul. 14 at 10:11 AM

0 · Reply

baerenmarkt Jul. 14 at 8:36 AM

$VALN Send it.

0 · Reply

Fib7867 Jul. 6 at 4:59 PM

#myVALNanalysis $VALN

0 · Reply

Boonkers Jun. 30 at 4:36 AM

$VALN

0 · Reply

Siuolman58 Jun. 27 at 1:12 PM

1 · Reply

PenkeTrading Jun. 26 at 5:45 AM

I found you an Oversold RSI (Relative Strength Index) on the daily chart of Valneva SE ADR. Is that bullish or bearish? $VALN #RsiOversold #NASDAQ

0 · Reply

Siuolman58 Jun. 17 at 7:48 PM

$VALN Just waiting for the Lyme Vaccine!!! Big Winner!

0 · Reply

stocksmanagement Jun. 5 at 9:38 PM

$VALN Check out this article from TipRanks | Valneva Announces Positive Phase 2 Results for Chikungunya Vaccine in Children | https://tipranks.onelink.me/WJho/bbal0dvw

0 · Reply

stocksmanagement Jun. 5 at 9:37 PM

$VALN good news

0 · Reply

TedBaker08 Jun. 5 at 5:42 PM

$VALN good news keep coming

0 · Reply

Dackel1909 May. 20 at 8:23 PM

$VALN 🤩

0 · Reply

Tjcmd May. 17 at 6:21 PM

$VALN ho hum

0 · Reply

Skywulf May. 12 at 7:59 AM

$VALN sadly we will see all pharma go down hard this week ☠️

0 · Reply

TheCheeseWrangler May. 7 at 3:54 PM

$VALN https://valneva.com/press-release/valneva-provides-update-following-european-medicines-agency-announcement-on-use-of-ixchiqin-elderly/

0 · Reply

Boonkers May. 7 at 5:16 AM

$VALN https://valneva.com/press-release/valneva-reports-first-quarter-2025-financial-results-and-provides-corporate-updates/

0 · Reply

TheCheeseWrangler May. 7 at 5:01 AM

$VALN https://valneva.com/press-release/valneva-reports-first-quarter-2025-financial-results-and-provides-corporate-updates/

0 · Reply

Armonica423 May. 7 at 1:59 AM

$VALN CYDY

0 · Reply

Chalutz May. 7 at 12:02 AM

$DVAX I also have a position in $VALN with its Lyme Disease vaccine. So glad to know DVAX mgmt is on the job flipping their shares, doing nothing in Europe and RIDICULOUSLY behind Pfizer and Valneva’s Lyme disease vaccine. Tute investors have to side with us and get rid of these crooks.

0 · Reply

ajmore May. 2 at 6:19 AM

$VALN RFK Jr. US to invest 500 mln in "new" Covid vaccine with whole virus inactivated! Are they going to buy the Valneva vaccine!

0 · Reply

Market Cap	552.26M
Revenue (ttm)	183.50M
Net Income (ttm)	-13.25M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-7.22%
Debt to Equity Ratio	1.03

Volume	7,100
Avg Vol	39,764
Day's Range	N/A - N/A
Shares Out	85.09M
Stochastic %K	78%
Beta	1.74
Analysts	Strong Sell
Price Target	$13.37